On May 22, 2023, CureVac N.V. (NASDAQ: CVAC) opened at $9.34, higher 6.73% from the last session. During the day, the shares moved up to $10.14 and dropped to $9.27 before settling in for the closing price of $9.06. Price fluctuations for CVAC have ranged from $5.63 to $20.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 42.00% at the time writing. With a float of $88.88 million, this company’s outstanding shares have now reached $216.34 million.
Let’s look at the performance matrix of the company that is accounted for 1049 employees. In terms of profitability, gross margin is -203.08, operating margin of -424.38, and the pretax margin is -369.56.
CureVac N.V. (CVAC) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of CureVac N.V. is 45.44%, while institutional ownership is 19.90%.
CureVac N.V. (CVAC) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/30/2022, the company posted -$0.65 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.33) by -$0.32. This company achieved a net margin of -369.37 while generating a return on equity of -38.72. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.00% per share during the next fiscal year.
CureVac N.V. (NASDAQ: CVAC) Trading Performance Indicators
Check out the current performance indicators for CureVac N.V. (CVAC). In the past quarter, the stock posted a quick ratio of 3.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 28.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.33, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -0.66 in one year’s time.
Technical Analysis of CureVac N.V. (CVAC)
CureVac N.V. (NASDAQ: CVAC) saw its 5-day average volume 0.54 million, a negative change from its year-to-date volume of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 70.42%. Additionally, its Average True Range was 0.54.
During the past 100 days, CureVac N.V.’s (CVAC) raw stochastic average was set at 55.99%, which indicates a significant decrease from 86.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.71% in the past 14 days, which was lower than the 91.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.58, while its 200-day Moving Average is $8.52. Nevertheless, the first resistance level for the watch stands at $10.12 in the near term. At $10.56, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.99. If the price goes on to break the first support level at $9.25, it is likely to go to the next support level at $8.82. Assuming the price breaks the second support level, the third support level stands at $8.38.
CureVac N.V. (NASDAQ: CVAC) Key Stats
There are currently 223,842K shares outstanding in the company with a market cap of 2.09 billion. Presently, the company’s annual sales total 71,030 K according to its annual income of -262,380 K. Last quarter, the company’s sales amounted to 11,689 K and its income totaled -128,784 K.
